Optimizing Medications to Your DNA
Why Precision Medicine is Important
Rx-Precision’s team leverages the established science of genomics to work with physicians, pharmacists and care teams to tailor and modify treatment based on each member’s individual genetics (DNA). Each of us have DNA that determines, among other factors, how we respond to medication and treatment. To be effective, medications must be processed through our DNA to be utilized in the body. However, many of us carry differences in our unique genetic makeup that cause us to respond to medication differently, potentially causing some medications to be ineffective, or even worse, harmful.
PGx-Guided Care is the process of analyzing an individual’s DNA to determine the best course of treatment for them individually, not simply based on trial and error, step therapy or standard clinical protocols. This process ensures that each individual we work with is prescribed medications that are going to be most beneficial and effective for them.
Management
Our Management and Advisory teams are made up of healthcare and technology experts that have
extensive experience in developing and deploying new, innovative, cutting-edge technologies and
clinical services in some of the country’s largest, most respected companies and successful start-ups.
Jake Velie
Founder & Chief Strategy Officer
Joshua Ridgeway
Co-Founder & Chief Operating Officer
Shital Patel
Chief Financial Officer
Dr. Ilene J. Klein
Strategic Advisor
Scientific Advisory Board
Scott Weissman
Genome Medical
Proactive Service Lead
Steve Bleyl
Genome Medical
Chief Medical Officer
Momo Vuyisich
Viome
Chief Science Officer
Guruduth Banavar
Viome
Chief Technical Officer
Tyler Koep
OneOme
Medical Affairs
Jason Ross
OneOme
Chief Technical Officer
Upcoming Events
Read More
For Payors
A turnkey pharmacogenomics risk management and medication optimization platform for employers, health plans, third-party administrators and other payors
The Study
Pharmacogenomic testing and case management for members with complex chronic disease
The Science
Numerous clinical studies have documented that PGx testing leads to improved clinical outcomes and significant costs savings in the right patient populations
Copyright 2019 © Rx-Precision, Inc. All rights reserved.
Rx-Precision, Inc.
2945 Townsgate Rd.
Suite #200
Westlake Village, CA 91361
Optimizing Medications to Your DNA
Why Precision Medicine is Important
Rx-Precision’s team leverages the established science of genomics to work with physicians, pharmacists and care teams to tailor and modify treatment based on each member’s individual genetics (DNA). Each of us have DNA that determines, among other factors, how we respond to medication and treatment. To be effective, medications must be processed through our DNA to be utilized in the body. However, many of us carry differences in our unique genetic makeup that cause us to respond to medication differently, potentially causing some medications to be ineffective, or even worse, harmful.
PGx-Guided Care is the process of analyzing an individual’s DNA to determine the best course of treatment for them individually, not simply based on trial and error, step therapy or standard clinical protocols. This process ensures that each individual we work with is prescribed medications that are going to be most beneficial and effective for them.
Upcoming Events
Management
Our Management and Advisory teams are made up of healthcare and technology experts that have
extensive experience in developing and deploying new, innovative, cutting-edge technologies and
clinical services in some of the country’s largest, most respected companies and successful start-ups.
Jake Velie
Founder & Chief Strategy Officer
Joshua Ridgeway
Co-Founder & Chief Operating Officer
Shital Patel
Chief Financial Officer
Dr. Ilene J. Klein
Strategic Advisor
Scientific Advisory Board
Scott Weissman
Genome Medical
Proactive Service Lead
Steve Bleyl
Genome Medical
Chief Medical Officer
Momo Vuyisich
Viome
Chief Science Officer
Guruduth Banavar
Viome
Chief Technical Officer
Tyler Koep
OneOme
Medical Affairs
Jason Ross
OneOme
Chief Technical Officer
Read More
For Payors
A turnkey pharmacogenomics risk management and medication optimization platform for employers, health plans, third-party administrators and other payors
The Study
Pharmacogenomic testing and case management for members with complex chronic disease
The Science
Numerous clinical studies have documented that PGx testing leads to improved clinical outcomes and significant costs savings in the right patient populations
Copyright 2019 © Rx-Precision, Inc. All rights reserved.
Rx-Precision, Inc.
2945 Townsgate Rd.
Suite #200
Westlake Village, CA 91361
As COO, Joshua designed, built and manages our case management operations which includes member enrollment, testing and all activities between the lab, member, genetic counselors and treating physicians.
Dr. Martin Kohn is an expert in health data analytics, health policy and healthcare management. He is an experienced physician, clinical informaticist, and health policy analyst. He was most recently Chief Medical Scientist at Sentrian, which creates predictive analytic systems integrating home monitoring with longitudinal health data for patients with complex chronic diseases. Sentrian identifies patients who are likely to need hospitalization days before they become seriously ill to provide time to intervene and avoid hospitalization. Previously, he was the Chief Medical Scientist for Care Delivery Systems in IBM Research developing analytic tools for healthcare, including the use of the Watson supercomputer.
Oren is an innovator and technologist with deep experience in healthcare, big data and analytics. He has over 20 years’ experience as an entrepreneur and startup leader. Oren has had proven success in leading the creation of new products, businesses and venture-backed portfolios both as an entrepreneur and in partnership with Fortune 500 / Global 1000 companies. Oren is passionate about building transformative solutions and highly effective teams. He has expertise in artificial intelligence, deep learning, and data science across financial services, healthcare, and industrial sectors. Oren’s recent experience includes being Co-Founder and President of Pivotus Ventures, a new breed of enterprise software company focused in the banking industry that recently sold to Kony. Previously he was General Partner and Chief Strategy and Technology officer at FDC, a venture fund and startup foundry based in Orange County, CA. At FDC Oren ran incubation and oversaw technology and strategy across a portfolio of over 20 new ventures created at FDC.
Roni has more 20 years of industry healthcare technology experience in roles as CTO, CIO and CISO at Health Systems, Pharmaceutical, Biotechnology, Payer, Academic, City/State Government and Medical device companies.
As Chief Financial Officer, Shital is responsible for all of the company’s financial functions including accounting, audit, treasury, corporate finance and investor relations. Shital also leads human resource and legal activities. Her career spans more than 15 years of varied experience in financial management, business leadership and corporate strategy for software companies. Prior to joining Rx-Precision, Shital held previous CFO and Management positions at Pivotus Ventures, Maana and Microsoft. Shital earned a Bachelors of Speech Communication from California State University of Fullerton.
Jake has owned and operated family medicine, integrated health, and behavioral health clinics where he saw first hand how clinical solutions and advancements based on precision medicine can change the way we treat disease.
Dean is a healthcare industry veteran and digital health pioneer with more than twenty years of hands-on digital health experience as a startup Founder, CEO, Chief Commercial Officer and VP of Sales. Dean also has experience as a Partner and Advisor for venture capital firms and startup incubators, accelerators and growth foundries.
Tyler Koep, PhD is a Medical Affairs Specialist at OneOme specializing in clinical research and data analytics. Tyler received his PhD from Mayo Graduate School with a focus in Biomedical Sciences in 2014 and completed a post-doctoral fellowship at the University of Minnesota in 2017. Dr. Koep has numerous publications within the field of epidemiology and public health and provides expertise in designing and executing clinical research studies. Further, Dr. Koep offers subject matter expertise across the field of pharmacogenomics, including scientific foundations of drug metabolism, cost-effectiveness of pharmacogenomic testing, and chronic disease applications
Guru is driven to develop and apply deep technology innovations to solve the big challenges, especially in health and education. He is known for his work on Microbiome Analytics, IBM Watson AI, Smarter Cities, Services Innovation, Mobile Computing, and Distributed Systems.
Dr. Bleyl is board-certified in medical genetics with a doctorate degree in human genetics and background experience spanning clinical care, academic research and oversight of clinical services across an integrated health system. Prior to this role, he directed the Clinical Genetics Institute (CGI) for Intermountain Healthcare, where he oversaw provision of genetic services, implementation of genetic testing stewardship and development of a system-wide infrastructure for storage and use of genomic data. Dr. Bleyl maintains an academic affiliation with the University of Utah, where his clinical practice focuses on cardiovascular genetics.